Advertisement
U.S. Markets open in 8 hrs 59 mins
S&P Futures
5,886.50 -9.75 (-0.17%) Dow Futures
43,121.00 -56.00 (-0.13%) Nasdaq Futures
20,472.25 -47.25 (-0.23%) Russell 2000 Futures
2,249.80 -5.70 (-0.25%) Crude Oil
70.43 -0.13 (-0.18%) Gold
2,749.80 +10.90 (+0.40%)
RespireRx Pharmaceuticals Inc. (RSPI)
OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
Follow
At close: 04:00PM EDT
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 613.26k |
| Enterprise Value | 4.20M |
| Trailing P/E | 0.02 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.66 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.22 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 0.0069 |
| 52 Week Low 3 | 0.0002 |
| 50-Day Moving Average 3 | 0.0009 |
| 200-Day Moving Average 3 | 0.0013 |
Share Statistics
| Avg Vol (3 month) 3 | 438.19k |
| Avg Vol (10 day) 3 | 406k |
| Shares Outstanding 5 | 471.74M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 356.09M |
| % Held by Insiders 1 | 6.63% |
| % Held by Institutions 1 | 0.00% |
| Shares Short (Nov 30, 2009) 4 | 126 |
| Short Ratio (Nov 30, 2009) 4 | 1.47 |
| Short % of Float (Nov 30, 2009) 4 | 0.61% |
| Short % of Shares Outstanding (Nov 30, 2009) 4 | 0.60% |
| Shares Short (prior month Oct 30, 2009) 4 | 245 |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | � |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jan 06, 2021 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Jan 06, 2021 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2022 |
| Most Recent Quarter (mrq) | Sep 30, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -1,104.95% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -2.17M |
| Diluted EPS (ttm) | -0.0200 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.36k |
| Total Cash Per Share (mrq) | 0 |
| Total Debt (mrq) | 2.78M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.01 |
| Book Value Per Share (mrq) | -0.04 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -247.57k |
| Levered Free Cash Flow (ttm) | -661.03k |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.